Actively managed fund

AXA Framlington Biotech Z Inc

ISIN
GB00BRJZVL27
Minimum investment
100,000 GBP

How good is this fund, really?

See the rating in the app

About AXA Framlington Biotech Z Inc

For long-term capital growth over five years or more, AXA Framlington Biotech Fund invests globally in biotechnology, genomic and medical research businesses, which must make up at least 80% of the portfolio. Company size is unrestricted, and a US tilt is expected given where most of the industry is located. AXA Investment Managers UK manages the fund actively and may take the NASDAQ Biotechnology Index into account. Its stock selection draws on company finances, management, profitability and growth prospects, with ESG scores as a further factor. Sector-specific guidelines and AXA's ESG Standards exclude, for instance, controversial weapons and tobacco production. These Z income units distribute income to holders. Ongoing charges stand at 0.82%, and five years is the suggested minimum investment period.

Watch this fund for free Add AXA Framlington Biotech Z Inc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy AXA Framlington Biotech Z Inc — platforms and fees

Sold on 4 platforms we follow.

AXA Framlington Biotech Z Inc — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds